Cas:1379821-80-3 2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole manufacturer & supplier

Chemical Name:2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole

CAS.NO:1379821-80-3

Synonyms:2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole

Molecular Formula:C₄₆H₃₂Cl₄N₆O₈

Molecular Weight:938.59368

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole Use and application,2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole technical grade,usp/ep/jp grade.

Related News: First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. 2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole manufacturer Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities. 2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole supplier The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. 2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole vendor If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role. 2-(2-Chloro-5-nitrophenyl)-1-[2-(2-chloro-5-nitrophenyl)-4-(2-chlorophenyl)-5-(3,4-dimethoxyphenyl)-2H-imidazol-2-yl]-5-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-1H-imidazole factory Under the high pressure of environmental protection, if Chinese API companies want to achieve sustainable operation, they must recognize the current situation, increase environmental investment, and carry out industrial upgrades, focusing on new product development, process improvement, CMO business and new technology research. And other businesses to carry out work to improve safety, environmental protection, quality, cost and other capabilities, so as to seize structural opportunities.